Skip to main content
Premium Trial:

Request an Annual Quote

Phylos Wins $358,326 for Cytokine Microarray Development

NEW YORK, June 17-Phylos said today that it had won a Phase II Small Business Innovation Research grant from the National Institute for Allergy and Infectious Disease.


The $358,326 grant, which lasts through 2004, will allow the company to continue developing a multiplexed cytokine microarray. The company's first SBIR grant for work on this technology was awarded in 1999.


Phylos is working to develop a high-throughput array-based platform to simultaneously measure different cytokine levels using only small amounts of biological sample.


The privately held company is based in Lexington, Mass.


For further information, see Phylos' press release.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.